Musculoskeletal Aging, Sarcopenia, and Cancer
The decrease in muscle mass and strength represents one of the most relevant descriptor of physiological aging. Sarcopenia is the term coined to indicate the pathologic loss of skeletal muscle mass and strength/function during aging. The skeletal muscle decline has a multifactorial origin, involving lifestyle habits, disease triggers, and age-dependent biological changes. This phenomenon is part of the geriatric background and is today starting to disseminate in other specialties dealing with the complexity of frail older persons. In the oncology field, the interest in muscle wasting has mostly been focused on the clinical entity of cancer cachexia, a complex metabolic syndrome characterized by severe muscle loss, systemic inflammation, and malnutrition. The study of body composition in the oncological setting is crucial and may become one of the main characterizations of the oncogeriatric field, where clinical and research actions have to be designed taking into account the consequences of the aging process.
KeywordsPhysical function Cachexia Muscle Body composition Aging
The authors thank Mr. Francesco Antognarelli for his invaluable assistance with the illustration (Fig. 2).
- Calvani R, et al. Systemic inflammation, body composition, and physical performance in old community-dwellers. J Cachexia Sarcopenia Muscle. 2016; https://doi.org/10.1002/jcsm.12134.
- Cesari M, et al. Biomarkers of sarcopenia in clinical trials-recommendations from the International Working Group on Sarcopenia. J Frailty Aging. 2012;1:102–10.Google Scholar
- Cesari M, et al. Sarcopenia-related parameters and incident disability in older persons: results from the “Invecchiare in Chianti” Study. J Gerontol A Biol Sci Med Sci. 2015;70:547–58.Google Scholar
- (1989) Epidemiologic and methodologic problems in determining nutritional status of older persons. In: Proceedings of a conference. Albuquerque, October 19–21, 1988. Am J Clin Nutr 50:1121–235. https://www.ncbi.nlm.nih.gov/pubmed/2816807.
- Global Burden of Disease Cancer Collaboration, et al. Global, Regional, and National Cancer Incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 Cancer Groups, 1990 to 2015: a systematic analysis for the Global Burden of Disease Study. JAMA Oncol. 2016; https://doi.org/10.1001/jamaoncol.2016.5688.
- Kalinkovich A, Livshits G. Sarcopenic obesity or obese sarcopenia: a cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis. Ageing Res Rev. 2016; https://doi.org/10.1016/j.arr.2016.09.008.
- Landi F, et al. Age-related variations of muscle mass, strength, and physical performance in community-dwellers: results from the Milan EXPO Survey. J Am Med Dir Assoc. 2016a; https://doi.org/10.1016/j.jamda.2016.10.007.
- Marzetti E, et al. Patterns of circulating inflammatory biomarkers in older persons with varying levels of physical performance: a partial least squares-discriminant analysis approach. Front Med (Lausanne). 2014;1:27.Google Scholar